Literature DB >> 27683608

Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension.

Tufik R Assad1, Evan L Brittain2, Quinn S Wells2, Eric H Farber-Eger3, Stephen J Halliday1, Laura N Doss2, Meng Xu4, Li Wang4, Frank E Harrell4, Chang Yu4, Ivan M Robbins1, John H Newman1, Anna R Hemnes1.   

Abstract

Although commonly encountered, patients with combined postcapillary and precapillary pulmonary hypertension (Cpc-PH) have poorly understood pulmonary vascular properties. The product of pulmonary vascular resistance and compliance, resistance-compliance (RC) time, is a measure of pulmonary vascular physiology. While RC time is lower in postcapillary PH than in precapillary PH, the RC time in Cpc-PH and the effect of pulmonary wedge pressure (PWP) on RC time are unknown. We tested the hypothesis that Cpc-PH has an RC time that resembles that in pulmonary arterial hypertension (PAH) more than that in isolated postcapillary PH (Ipc-PH). We analyzed the hemodynamics of 282 consecutive patients with PH referred for right heart catheterization (RHC) with a fluid challenge from 2004 to 2013 (cohort A) and 4,382 patients who underwent RHC between 1998 and 2014 for validation (cohort B). Baseline RC time in Cpc-PH was higher than that in Ipc-PH and lower than that in PAH in both cohorts (P < 0.001). In cohort A, RC time decreased after fluid challenge in patients with Ipc-PH but not in those with PAH or Cpc-PH (P < 0.001). In cohort B, the inverse relationship of pulmonary vascular compliance and resistance, as well as that of RC time and PWP, in Cpc-PH was similar to that in PAH and distinct from that in Ipc-PH. Our findings demonstrate that patients with Cpc-PH have pulmonary vascular physiology that resembles that of patients with PAH more than that of Ipc-PH patients. Further study is warranted to identify determinants of vascular remodeling and assess therapeutic response in this subset of PH.

Entities:  

Keywords:  postcapillary; precapillary; pulmonary hypertension; pulmonary vascular compliance; pulmonary vascular resistance; resistance-compliance time

Year:  2016        PMID: 27683608      PMCID: PMC5019084          DOI: 10.1086/688516

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  48 in total

1.  Pulmonary vascular resistance. A meaningless variable?

Authors:  Robert Naeije
Journal:  Intensive Care Med       Date:  2003-04       Impact factor: 17.440

2.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

3.  Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension.

Authors:  Srijoy Mahapatra; Rick A Nishimura; Paul Sorajja; Stephen Cha; Michael D McGoon
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

4.  Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension.

Authors:  Jan-Willem Lankhaar; Nico Westerhof; Theo J C Faes; C Tji-Joong Gan; Koen M Marques; Anco Boonstra; Fred G van den Berg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2008-03-17       Impact factor: 29.983

5.  Design of the REVEAL registry for US patients with pulmonary arterial hypertension.

Authors:  Michael D McGoon; Abby Krichman; Harrison W Farber; Robyn J Barst; Gary E Raskob; Theodore G Liou; Dave P Miller; Kathy Feldkircher; Scott Giles
Journal:  Mayo Clin Proc       Date:  2008-08       Impact factor: 7.616

6.  Development of a large-scale de-identified DNA biobank to enable personalized medicine.

Authors:  D M Roden; J M Pulley; M A Basford; G R Bernard; E W Clayton; J R Balser; D R Masys
Journal:  Clin Pharmacol Ther       Date:  2008-05-21       Impact factor: 6.875

7.  Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension.

Authors:  V Castelain; P Hervé; Y Lecarpentier; P Duroux; G Simonneau; D Chemla
Journal:  J Am Coll Cardiol       Date:  2001-03-15       Impact factor: 24.094

8.  Quantification of right ventricular afterload in patients with and without pulmonary hypertension.

Authors:  Jan-Willem Lankhaar; Nico Westerhof; Theo J C Faes; Koen M J Marques; J Tim Marcus; Piet E Postmus; Anton Vonk-Noordegraaf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-12       Impact factor: 4.733

9.  Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.

Authors:  Juan F Delgado; Esther Conde; Violeta Sánchez; Fernando López-Ríos; Miguel A Gómez-Sánchez; Pilar Escribano; Teresa Sotelo; Agustín Gómez de la Cámara; José Cortina; Carlos S de la Calzada
Journal:  Eur J Heart Fail       Date:  2005-10       Impact factor: 15.534

10.  Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure.

Authors:  Scott D Halpern; Darren B Taichman
Journal:  Chest       Date:  2009-03-02       Impact factor: 9.410

View more
  21 in total

1.  Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.

Authors:  Barry A Borlaug; Masaru Obokata
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

2.  Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study.

Authors:  Evan L Brittain; Meredith S Duncan; Joyce Chang; Olga V Patterson; Scott L DuVall; Cynthia A Brandt; Kaku A So-Armah; Matthew Goetz; Kathleen Akgun; Kristina Crothers; Courtney Zola; Joon Kim; Cynthia Gibert; Margaret Pisani; Alison Morris; Priscilla Hsue; Hilary A Tindle; Amy Justice; Matthew Freiberg
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

3.  Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University.

Authors:  Alexander R Opotowsky; Edward Hess; Bradley A Maron; Evan L Brittain; Anna E Barón; Thomas M Maddox; Laith I Alshawabkeh; Bradley M Wertheim; Meng Xu; Tufik R Assad; Jonathan D Rich; Gaurav Choudhary; Ryan J Tedford
Journal:  JAMA Cardiol       Date:  2017-10-01       Impact factor: 14.676

4.  Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension.

Authors:  Tufik R Assad; Anna R Hemnes; Emma K Larkin; Andrew M Glazer; Meng Xu; Quinn S Wells; Eric H Farber-Eger; Quanhu Sheng; Yu Shyr; Frank E Harrell; John H Newman; Evan L Brittain
Journal:  J Am Coll Cardiol       Date:  2016-12-13       Impact factor: 24.094

Review 5.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

Review 6.  Pulmonary Hypertension in Heart Failure.

Authors:  Albert Youngwoo Jang; Su Jung Park; Wook-Jin Chung
Journal:  Int J Heart Fail       Date:  2021-04-21

7.  Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rebecca R Vanderpool; Melissa Saul; Mehdi Nouraie; Mark T Gladwin; Marc A Simon
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

8.  Features Associated With Discordance Between Pulmonary Arterial Wedge Pressure and Left Ventricular End Diastolic Pressure in Clinical Practice: Implications for Pulmonary Hypertension Classification.

Authors:  Anna R Hemnes; Alexander R Opotowsky; Tufik R Assad; Meng Xu; Laura N Doss; Eric Farber-Eger; Quinn S Wells; Evan L Brittain
Journal:  Chest       Date:  2018-08-24       Impact factor: 9.410

9.  Pulmonary vascular distensibility with passive leg raise is comparable to exercise and predictive of clinical outcomes in pulmonary hypertension.

Authors:  Callyn J Kozitza; Naga Dharmavaram; Ran Tao; Diana M Tabima; Naomi C Chesler; Farhan Raza
Journal:  Pulm Circ       Date:  2022-01-12       Impact factor: 2.886

10.  Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension.

Authors:  Tufik R Assad; Bradley A Maron; Ivan M Robbins; Meng Xu; Shi Huang; Frank E Harrell; Eric H Farber-Eger; Quinn S Wells; Gaurav Choudhary; Anna R Hemnes; Evan L Brittain
Journal:  JAMA Cardiol       Date:  2017-12-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.